ancient DNA for Modern Genomics (aDMG) Coordination Center
ID: 359207Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is preparing to solicit applications for the establishment of an ancient DNA for Modern Genomics (aDMG) Coordination Center, aimed at creating an ethical resource of ancient and historical human DNA data to enhance research on contemporary human traits and biology. The initiative will involve collaboration with researchers and local communities to identify and oversee sources of ancient DNA, fostering interdisciplinary investigations that integrate DNA sequencing, computational genomics, and insights into human evolution. With an estimated total program funding of $1.5 million and a projected award date of October 30, 2026, interested small businesses are encouraged to prepare for application submission, with the synopsis expected to be published by December 1, 2025. For further inquiries, potential applicants can contact Jennifer Troyer at jennifer.troyer@nih.gov or by phone at 301-312-3276.

    Point(s) of Contact
    Jennifer Troyer National Human Genome Research Institute (NHGRI)
    (301) 312-3276
    jennifer.troyer@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    ancient DNA for Modern Genomics (aDMG) Data Generation and Resource Center
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing an upcoming funding opportunity for the establishment of an ancient DNA for Modern Genomics (aDMG) Data Generation and Resource Center. This initiative aims to create an ethical resource of ancient and historical human DNA data to enhance research on contemporary human traits and biology, with a focus on producing high-quality whole-genome sequence data from approved ancient DNA sources. The program is significant for advancing studies in population genomics and human evolution, encouraging collaborations among experts in DNA sequencing, computational genomics, and related fields. The estimated total program funding is $2,750,000, with one award expected, and interested applicants should prepare for the application process, which will open following the publication of the Notice of Funding Opportunity (NOFO) in December 2025, with a closing date in March 2026. For further inquiries, potential applicants can contact Jennifer Troyer at jennifer.troyer@nih.gov or by phone at 301-312-3276.
    Centers for Genomics Research Capacity Building
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Centers for Genomics Research Capacity Building," aimed at enhancing genomics research capabilities at biomedical institutions. This initiative seeks applications from small businesses to establish Genomic Research Centers that will support interdisciplinary teams in developing innovative genomic research projects addressing critical issues such as genomic technology, disease genomics, and the ethical implications of genomic research. With an estimated total program funding of $5 million and the expectation of awarding three grants, interested applicants are encouraged to begin forming collaborations and developing proposals, with the anticipated synopsis posting date on December 1, 2025, and a closing date for applications on March 2, 2026. For further inquiries, potential applicants can contact Jennifer Troyer at jennifer.troyer@nih.gov or by phone at 301-312-3276.
    IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is seeking applications for the Impact of Genomic Variation on Function (IGVF) Data and Coordinating Center (DACC) through a cooperative agreement. The DACC will serve as the central hub for the IGVF Consortium, tasked with developing a comprehensive data portal and cataloging variant impacts, while also facilitating consortium activities and collaborations within the broader research community. This initiative is crucial for enhancing the understanding of genomic variation and its implications in health. The estimated total program funding is $1,200,000, with one award anticipated, and the application process is expected to open in 2025, with a due date later that year. For further inquiries, interested applicants can contact Dr. Stephanie A. Morris at morriss2@mail.nih.gov or by phone at 301-435-5738.
    Clinical Data Ecosystem for Genomics (CDEG)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Clinical Data Ecosystem for Genomics (CDEG), aimed at establishing a network to enhance the integration and sharing of genomic sequencing data among healthcare providers, labs, and patients. The initiative seeks to reduce barriers to clinical data sharing by creating a pilot ecosystem that demonstrates best practices, developing standardized APIs, and producing open-source clinical software applications that facilitate access to genomic data across various healthcare settings. This cooperative agreement is particularly relevant for small businesses with expertise in genomic medicine, data science, and health information exchange, and interested applicants are encouraged to begin forming collaborations in anticipation of the application process. For further inquiries, potential applicants can contact Jennifer Troyer at jennifer.troyer@nih.gov or by phone at 301-312-3276. The estimated synopsis post date is December 1, 2025, with applications expected to close by March 2, 2026, and awards anticipated by October 30, 2026.
    Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype," aimed at small businesses. This initiative seeks to support research that characterizes genomic variation and assesses the impact of individual variants on genome function through high-throughput methods, data collection on molecular and cellular phenotypes, and the development of robust data processing pipelines. The initiative is part of the Impact of Genomic Variation on Function (IGVF) Consortium, which will facilitate collaboration among funded centers to ensure resource accessibility and shared analysis strategies. The estimated total program funding is $3 million, with five awards expected, and the application process is anticipated to open in 2025, with a due date later that year. For further inquiries, interested applicants can contact Dr. Stephanie A. Morris at morriss2@mail.nih.gov or by phone at 301-435-5738.
    Centers of Excellence in Genomic Science (CEGS)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Centers of Excellence in Genomic Science (CEGS) program, aimed at fostering interdisciplinary research teams to tackle significant biomedical challenges from a genomics perspective. The initiative seeks to develop innovative concepts, methods, and technologies that can lead to transformative advancements in genomic science, genomic medicine, and computational genomics, with a focus on high-risk, high-reward projects that are unlikely to be pursued through standard funding mechanisms. With an estimated total program funding of $5 million and the expectation of awarding two grants, interested applicants can reach out to Stephanie A. Morris at morriss2@mail.nih.gov or call 301-435-5738 for further information. The application process is set to open with a synopsis posting on March 25, 2026, and will close on June 24, 2026, with awards anticipated by April 1, 2027.
    Illuminating AD/ADRD Genome to Enable Precision Genomic Medicine
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Illuminating AD/ADRD Genome to Enable Precision Genomic Medicine," aimed at supporting integrative, cross-disciplinary research projects focused on understanding the genomic factors involved in Alzheimer's Disease (AD) and Alzheimer's Disease Related Dementias (ADRD). The initiative seeks to leverage innovative techniques and advanced analytical methods, including machine learning and comparative genomic analysis, to explore the genomic drivers of neurodegeneration through sophisticated disease models and interdisciplinary approaches. This cooperative agreement does not require cost sharing and is open to a wide range of eligible applicants, including non-domestic entities and tribal governments, with applications expected to be solicited starting in August 2026. For further inquiries, interested parties may contact Dr. Alison Yao at 301-827-7264 or via email at yaoal@nia.nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for ClinGen Genomic Curation Expert Panels
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the establishment and continuation of Genomic Curation Expert Panels under the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The objective of this funding opportunity is to solicit applications from small businesses to manually curate, review, and define the clinical relevance of genes and variants, addressing the challenge of genomic variants with unknown significance that hinder advancements in genomic and precision medicine. This initiative is crucial for enhancing the understanding of the links between genes, variants, and diseases, ultimately contributing to a centralized public resource for expert-curated genetic data. The estimated total program funding is $880,000, with four expected awards, and interested applicants can contact Dr. Julia Jiaqi O'Reilly at Jiaqi.OReilly@nih.gov or 240-328-8649 for further information. Key deadlines include an estimated synopsis post date of March 25, 2026, and a close date of May 25, 2026, with awards anticipated by April 1, 2027.
    Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity for the Genome Sequencing Center as part of the Gabriella Miller Kids First Pediatric Research Program, aimed at advancing research into childhood cancer and congenital anomalies. This initiative will support the addition of data to existing resources, enhance data types as technologies evolve, and incorporate clinic-based data sources to better understand the genetic pathways of these disorders. With an estimated total program funding of $6.6 million, this cooperative agreement does not require cost sharing and is open to small businesses. Interested applicants are encouraged to prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis posting date of July 30, 2025, and a closing date of October 30, 2025. For further inquiries, potential applicants can contact Dr. Concepcion R. Nierras at 301-435-5840 or via email at concepcion.nierras@nih.gov.
    Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Genomic Variant Interactions With Other Variants Or The Environment," aimed at studying the effects of genetic and environmental interactions on genomic variant impact. This initiative seeks to establish research frameworks that will experimentally test combinations of variants to identify significant interactions that could enhance the understanding of Genome-wide Association Studies (GWAS) and improve polygenic scores. The total estimated funding for this program is $10 million, with approximately five awards expected to be made. Interested applicants, including small businesses and eligible foreign entities, should prepare for the anticipated Notice of Funding Opportunity (NOFO) publication in 2025, with applications due later that year. For further inquiries, contact Mike Pazin at michael.pazin@nih.gov or by phone at 301-480-2629.